title: Voluntary wheel running in growing rats does not protect against doxorubicin-induced osteopenia.
abstract: There is growing concern regarding the long-term negative side effects of chemotherapy in childhood cancer survivors. Doxorubicin (DOX) is commonly used in the treatment of childhood cancers and has been shown to be both cardiotoxic and osteotoxic. It is unclear whether exercise can attenuate the negative skeletal effects of this chemotherapy. Rat pups were treated with saline or DOX. Animals remained sedentary or voluntarily exercised. After 10 weeks, femoral bone mineral content and bone mineral density were measured using dual-energy x-ray absorptiometry. Cortical and cancellous bone architecture was then evaluated by microcomputed tomography. DOX had a profound negative effect on all measures of bone mass and cortical and cancellous bone architecture. Treatment with DOX resulted in shorter femora and lower femoral bone mineral content and bone mineral density, lower cross-sectional volume, cortical volume, marrow volume, cortical thickness, and principal (IMAX, IMIN) and polar (IPOLAR) moments of inertia in the femur diaphysis, and lower cancellous bone volume/tissue volume, trabecular number, and trabecular thickness in the distal femur metaphysis. Exercise failed to protect bones from the damaging effects of DOX. Other modalities may be necessary to mitigate the deleterious skeletal effects that occur in juveniles undergoing treatment with anthracyclines.
authors.affiliation: School of Sport and Exercise Science, University of Northern Colorado, Greeley, CO 80639, USA. reid.hayward@unco.edu
authors.forename: Reid
authors.initials: R
authors.lastname: Hayward
authors.forename: Urszula T
authors.initials: UT
authors.lastname: Iwaniec
authors.forename: Russell T
authors.initials: RT
authors.lastname: Turner
authors.forename: Chia-Ying
authors.initials: CY
authors.lastname: Lien
authors.forename: Brock T
authors.initials: BT
authors.lastname: Jensen
authors.forename: David S
authors.initials: DS
authors.lastname: Hydock
authors.forename: Carole M
authors.initials: CM
authors.lastname: Schneider
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000633:toxicity*; D001835:Body Weight / Q000187:drug effects / Q000502:physiology; D001846:Bone Development / Q000187:drug effects / Q000502:physiology; D001851:Bone Diseases, Metabolic / Q000139:chemically induced* / Q000517:prevention & control*; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism; D002113:Calcification, Physiologic / Q000187:drug effects / Q000502:physiology; D004317:Doxorubicin / Q000633:toxicity*; D005269:Femur / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012420:Running / Q000502:physiology*
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin